The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: An Australian multicenter study

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 6, 1996, Pages 605-616

  Chang, Annabella ^a   Ma, David D F ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0030445172     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.605     Document Type: Article

References (35)

1. Siena, S., Bregni, M., Brando, B., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
2. Berenson, R.J., Bensinger, W.I., Hill, R.S., et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991.
3. Bender, J.G., Williams, S.F., Myers S, et al. Characterisation of chemotherapy mobilised peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant. 10:281, 1992.
4. Haas, R., Mohle, R., Fruhauf, S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994.
5. Korbling, M., Przepiorka, D., Huh, Y.O., et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995.
6. Serke, S., Sauberlich, S. & Huhn, D. Multiparameter flow cytometrical quantitation of circulating CD34+ cells: Correlation to the quantitation of circulating hematopoietic progenitor cells by in vitro colony assay. Br. J. Haematol. 77:453, 1991.
7. Boiron, J.M., Marit, G., Faberes, C., et al. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant. 12:49, 1993.
8. Bender, J.G., To, L.B., Williams, S., et al. Defining a therapeutic dose of peripheral blood stem cells. J. Hematother. 1:329, 1992.
9. Hohaus, S., Goldschmidt, H., Ehrhardt, R., et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp. Hematol. 21:508, 1993.
10. Zimmerman, T.M., Lee, W.J., Bender, J.G., et al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant. 15:439, 1995.
11. de Wynter, E.A., Coutinho, L.H., Pei, X., et al. Comparison of purity and enrichment of CD34(+) cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells 13:524, 1995.
12. Dreger, P., Viehmann, K., Steinmann, J., et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Exp. Hematol. 23:147, 1995.
13. Silvestri, F., Wunder, E., Sovalat, H., et al. Positive selection of CD34+ cells: A short review of the immunoadsorption methods currently available for experimental and clinical use. J. Hematother. 2:473, 1993.
14. - hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: Implications for gene transduction and/or transplantation. Bone Marrow Transplant. 13:649, 1994.
15. Haylock, D.N., To, L.B., Dowse, T.L., et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80:1405, 1992.
16. + stem cell content of peripheral blood collections. Exp. Hematol. 23:1619, 1995.
17. Sovalat, S. & Serke, S. Identification of CD34-positive cells by multiparameter flow cytometry. In Peripheral blood stem cell transplantation, eds. Wunder, E.W. & Henon, P.R. Springer-Verlag, Heidelberg, 1993, p. 107.
18. Bender, J.G., Unverzagt, K., Walker, D.E., et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591, 1991.
19. Sutherland, D.R., Keating, A., Nayar, R., et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp. Hematol. 22:1003, 1994.
20. Bender, J.G., Unverzagt, K. & Walker, D. Guidelines for determination of CD34+ cells by flow cytometry: Application to the harvesting and transplantation of peripheral blood stem cells. In The Mulhouse manual, eds. Wunder, E., Sovalat, H., Henon, P., et al. AlphaMed Press, Dayton, Ohio, 1994, p. 31.
21. Siena, S., Bregni, M., Di Nicola, M., et al. Milan protocol for clinical CD34+ cell estimation in peripheral blood for antografting in patients with cancer In The Mulhouse manual, eds. Wunder, E., Sovalat, H., Henon, P., et al. AlphaMed Press, Dayton, Ohio, 1994, p. 23.
22. Trischmann, T.M., Schepers, K.G., & Civin, C.I. Measurement of CD34+ cells in bone marrow by flow cytometry. J. Hematother. 2:305, 1993.
23. Sauberlich, S., Kirsch, A. & Serke, S. Determination of CD34+ hemopoietic cells by multiparameter flow cytometry: Technical remarks. In The Mulhouse manual, eds. Wunder, E., Sovalat, H., Henon, P., et al. AlphaMed Press, Dayton, Ohio, 1994, p. 45.
24. Wunder, E., Sovalat, H., Fritsch, G., et al. Report on the European workshop on peripheral blood stem cell determination and standardization, Mulhouse, France. J. Hematother. 1:131, 1992.
25. Sovalat, H., Wunder, E., Tienharra, A., et al. Commentary: Prospects for standardization of stem cell determination within Europe. J. Hematother. 3:293, 1993.
26. Bender, J.G. & Unverzagt, K. Flow cytometric analysis of peripheral blood stem cells. J. Hematother. 2:421, 1993.
27. Johnsen, H.E. Report from a Nordic Workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J. Hematother. 4:21, 1995.
28. Sutherland, D.R. CD34+ measurements: What are the standards? ISHAGE Telegraft 2:(1)3, 1995.
29. Chen, C.H., Lin, W., Shye, S., et al. Automated enumeration of CD34+ cells in peripheral blood and bone marrow. J. Hematother. 3:3, 1994.
30. Brecher, M.E., Sims, L., Schmitz, J., et al. North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J. Hematother. 5:227, 1996.
31. Lowdell, M.W. & Bainbridge, D.R. External quality assurance for CD34 cell enumeration - Results of a preliminary national trial. Bone Marrow Transplant. 17:849, 1996.
32. Haas, R., Witt, B., Mohle, R., et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 85:3754, 1995.
33. Bensinger, W., Appelbaum, F., Rowley, S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J. Clin. Oncol. 13:2547, 1995.
34. Sutherland, D.R., Anderson, L., Keeney, M., et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J. Hematother. 5:213, 1996.
35. Titley, I., Healy, L.E., Scott, M., et al. Extent of variability inherent in measurements of CD34-positive cells in different human haemopoietic tissues. Bone Marrow Transplant. 16:611, 1995.